About Us

Welcome to Zeta Pharma

Zeta Pharma is fast-growing Egyptian company that was established in 2010 to represent an added value in the pharmaceutical industry.

Zeta Pharma had a well selected and unique product portfolio in all therapeutic areas.

Zeta Pharma Has started its marketing activities in 2015 on the products for Hepatitis C Virus (Sofocivir, Zetaciver & Sofocivir Plus).

In collaboration with the Egyptian Ministry of Health and Egyptian Liver Research Institute, ZETA PHARMA® has managed to treat more than 60,000 patients with healing rates 95 % similar to those of the global rate.

Our Mission & Vision

Our Vision

We strive to be one of the most community trusted pharma partners who care about people’s quality of life in Middle East –Africa region

Our Mission

We are committed to provide our communities across the Middle East-Africa region with affordable, high-quality pharmaceutical integrated solutions. Our state of art production facility designed to comply with GMP and WHO standards. ZETA PHARMA® also invests in human capital through attracting, cultivating and retaining excellent talents with passionate commitment to ZETA PHARMA’S work ethic and strong core values. Integrating the most cutting-edge science with the best human caliber in the market allows us to serve as a reliable partner in the healthcare system.

Zeta Pharma Factory

ZETA Pharma maintains one of the broadest quality-products portfolio within the industry and as an optimistic view to the future, the board decided to establish a manufacturing facility comply with the cGMP Standards in 7500 m2 area.

Zeta History

Cool Timeline

2022
September

2022 launched New 9 Products

2022 launched New 9 Products

1-Nexirozova Launch:

Jan – 2022, Zeta Pharma launched Nexirozova; a new generic of the anti-dyslipidemic molecule Rosuvastatin 5,10,20mg,

Click Here To See More.

2021
December

2021 Launched New 7 Products

2021 Launched New 7 Products

1- Bilastegic Launch:

Jan – 2021, Zeta Pharma launched its new product, Bilastegic the world’s latest and most effective product for allergic diseases,

Click Here To See More.

2020
July

EBRD Agreement 2020

EBRD Agreement 2020

The European Bank for Reconstruction and Development (EBRD) is providing consultancy studies to Zeta Pharma factory in Egypt to qualify for European GMP accreditation.

Click Here To See More.

April

2020 Launched New 4 Products

2020 Launched New 4 Products

1- Empacoza Lunch:

Zeta Pharma launches “Empacoza” type 2 diabetes medicine in the Egyptian Market, In presence of famous Egyptian professors of Internal medication and endocrinology,

Click Here To See More.

2019
May

2019 Launched New 5 Products

2019 Launched New 5 Products

1- Ancavaz Launch:

Zeta launched Ancavaz -which is indicated as a substitution therapy for the treatment of hypertension and/or stable coronary heart disease,

Click Here To See More.

2018
October

2018 Launched 4 New Products

2018 Launched 4 New Products

1- Nexicure Launch:

12/10/2018

Zeta launched Nexicure Esomeprazole 20/40 mg MUPS tablet,

Click Here To See More.

2017
December

100 Millions Seha

100 Millions Seha

Interview with Major General Mahmoud Ashmawi, Governor of Qalyubia governorate, and Dr. Hamdi El Tabakh, the Ministry of Health representative in Qalyubia in the launch of the Hepatitis C eradication campaign,

Click Here To See More.

2015
December

HCV Launch

HCV Launch

Zeta Pharma Has started its marketing activities in 2015 on the products for Hepatitis C Virus (Sofocivir, Zetaciver & Sofocivir Plus).

Click Here To See More.